![Amy Reilly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Reilly
Contacto de Relaciones con Inversores en DYNE THERAPEUTICS, INC. .
Cargos activos de Amy Reilly
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/07/2020 | - |
Public Communications Contact | 01/07/2020 | - |
Historial de carrera de Amy Reilly
Antiguos cargos conocidos de Amy Reilly.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Contacto de Relaciones con Inversores | 01/09/2018 | 01/05/2020 |
Public Communications Contact | 01/11/2017 | 01/05/2020 | |
THERMO FISHER SCIENTIFIC | Public Communications Contact | 01/03/2017 | 01/10/2017 |
IMMUNOGEN, INC. | Public Communications Contact | 01/10/2015 | 01/03/2017 |
CUBIST PHARMACEUTICALS INC | Public Communications Contact | 01/01/2011 | 01/01/2015 |
Formación de Amy Reilly.
Bowdoin College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Public Communications Contact | 5 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Empresas privadas | 2 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ImmunoGen, Inc.
![]() ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Amy Reilly
- Experiencia